- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Triple Hit Lymphoma in United Kingdom
Total 11599 results
-
GlaxoSmithKlineCompletedLymphoma, Non-HodgkinUnited States, France, United Kingdom
-
International Extranodal Lymphoma Study Group (IELSG)CompletedLymphoma, Mucosa-Associated Lymphoid TissueUnited Kingdom, France, Italy, Switzerland, Spain, Belgium
-
Cancer Research UKUnknownLymphoma | Small Intestine CancerUnited Kingdom
-
Kyowa Kirin, Inc.CompletedAdult T-cell Leukemia-LymphomaUnited States, United Kingdom, Belgium, France, Brazil, Peru
-
St. Jude Children's Research HospitalCompletedLymphoblastic LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedHIV Infection | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular... and other conditionsUnited States
-
Eli Lilly and CompanyCompletedColorectal Cancer | Mantle Cell Lymphoma | Advanced CancerUnited States, France, United Kingdom
-
Eureka Therapeutics Inc.Duke University; Duke Clinical Research InstituteTerminatedLymphomas Non-Hodgkin's B-CellUnited States
-
Dana-Farber Cancer InstituteHiberCell, Inc.CompletedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasUnited States
-
Robert LowskyNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Recurrent Small Lymphocytic...United States
-
Catherine BollardNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsRecruitingHIV Associated LymphomaUnited States
-
ImmunityBio, Inc.WithdrawnTriple Negative Breast Cancer (TNBC)United States
-
National Cancer Institute (NCI)RecruitingImmune System Diseases | Lymphoproliferative Disorders | Peripheral T-cell LymphomasUnited States
-
BayerCompleted
-
Laura KennedyNational Cancer Institute (NCI)SuspendedBreast Cancer | Triple-negative Breast CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma and other conditionsUnited States
-
Washington University School of MedicineSusan G. Komen Breast Cancer FoundationCompletedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast CancerUnited States
-
NuCana plcRecruitingMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Advanced Cancer | Head and Neck Squamous Cell Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Neoplasm Malignant | Pleural... and other conditionsUnited Kingdom
-
The Christie NHS Foundation TrustCompletedHodgkin LymphomaUnited Kingdom
-
University of Alabama at BirminghamGlaxoSmithKline; AbbVie; Breast Cancer Research Foundation of AlabamaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States
-
Case Comprehensive Cancer CenterCompletedMetastatic Triple Negative Breast CancerUnited States
-
Texas Tech University Health Sciences Center, El...RecruitingTriple-negative Breast CancerUnited States
-
George T. BuddUnited States Department of Defense; Anixa Biosciences, Inc.RecruitingResidual Disease | TNBC - Triple-Negative Breast Cancer | Pathologic Stage IIA-IIIC Triple-Negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Cancer Research UKUnknown
-
The Methodist Hospital Research InstituteCompletedMetastatic Triple Negative Breast CancerUnited States
-
Medical College of WisconsinRecruitingFollicular Lymphoma | Multiple Myeloma | Burkitt Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Lymphoma, Small Lymphocytic | Diffuse Large B Cell Lymphoma | Central Nervous System Lymphoma | Lymphomas Non-Hodgkin's B-CellUnited States
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited States, United Kingdom
-
University of WashingtonBayerTerminatedNon-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Lymphoid LeukemiaUnited States
-
Yale UniversityIovance Biotherapeutics, Inc.CompletedMetastatic Triple Negative Breast CancerUnited States
-
ImmunityBio, Inc.TerminatedAdvanced Triple Negative Breast CancerUnited States
-
Texas Tech University Health Sciences Center, El...SuspendedMetastatic Triple-Negative Breast CancerUnited States
-
Ayala Pharmaceuticals, Inc,TerminatedTriple Negative Breast CancerUnited States, Belgium, Israel, Spain, United Kingdom
-
Eisai Inc.Completed
-
St. Jude Children's Research HospitalNational University, SingaporeCompletedLymphoblastic LymphomaUnited States
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC; G1 Therapeutics, Inc.RecruitingMetastatic Triple-Negative Breast CancerUnited States
-
Kartos Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaBelgium, Korea, Republic of, United States, United Kingdom, Italy, Switzerland, Australia, France, Poland, Portugal, Czechia
-
The Christie NHS Foundation TrustUniversity of ManchesterEnrolling by invitation
-
Acerta Pharma BVActive, not recruitingActivated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)United States, United Kingdom
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular... and other conditionsUnited States
-
Nippon Kayaku Co., Ltd.CompletedAdvanced Solid Tumors | Metastatic Triple Negative Breast CancerUnited States
-
Nurix Therapeutics, Inc.RecruitingCervical Cancer | Gastric Cancer | Head and Neck Squamous Cell Carcinoma | Non-small Cell Lung Cancer (NSCLC) | Metastatic Urothelial Carcinoma | Ovarian Cancer, Epithelial | Metastatic Castration-resistant Prostate Cancer (mCRPC) | Triple Negative Breast Cancer (TNBC) | Malignant Pleural Mesothelioma... and other conditionsUnited States, United Kingdom
-
Kymera Therapeutics, Inc.SuspendedNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | DLBCL | MYD88 Gene MutationUnited States, United Kingdom
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy
-
NuGenerex Immuno-OncologyMerck Sharp & Dohme LLC; NSABP Foundation IncActive, not recruiting
-
University College, LondonCancer Research UK; Cancer Research UK & UCL Cancer Trials CentreCompleted
-
Roswell Park Cancer InstituteNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Refractory Triple-Negative Breast CarcinomaUnited States
-
Gilead SciencesCompletedInvasive Fungal DiseaseUnited Kingdom
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingT-cell Acute Lymphoblastic Lymphoma | T-non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterCompletedLymphoblastic Lymphoma | Lymphoblastic LeukemiaUnited States